Distinct gene expression profiles associated with the susceptibility of pathogen-specific CD4+ T cells to HIV-1 infection

Background HIV infection causes the progressive depletion of CD4+ T cells. Contrary to the early loss of CD4 response to opportunistic pathogens like Candida albicans, cytomegalovirus (CMV)-specific CD4 response is persistent when total CD4+ T cell number is low. The mechanism is less clear. Despite considerable knowledge for the impact of HIV infection on total CD4+ T cells and their subsets, little is known about HIV infection of CD4+ T cells of different pathogen/antigen (Ag) specificity.

[1]  R. Guttu.  Oral candidiasis in high risk patients as the initial manifestation of the acquired immunodeficiency syndrome , 1984 .

[2]  J. Phair,et al.  Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus. , 1992, Journal of acquired immune deficiency syndromes.

[3]  J. Skowroński,et al.  CD4 down-regulation by nef alleles isolated from human immunodeficiency virus type 1-infected individuals. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[4]  O. Ramilo,et al.  Role of CD25+ and CD25-T cells in acute HIV infection in vitro. , 1993, Journal of immunology.

[5]  S. Arya,et al.  Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. , 1995, Science.

[6]  D. Weissman,et al.  HIV replication in CD4+ T cells of HIV-infected individuals is regulated by a balance between the viral suppressive effects of endogenous beta-chemokines and the viral inductive effects of other endogenous cytokines. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[7]  D. Weissman,et al.  Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. , 1996, Journal of immunology.

[8]  Steven M. Wolinsky,et al.  Relative resistance to HIV–1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high–risk sexual exposures , 1996, Nature Medicine.

[9]  C. Pitcher,et al.  Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency. , 1997, The Journal of clinical investigation.

[10]  O. Ramilo,et al.  Highly purified CD25- resting T cells cannot be infected de novo with HIV-1. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome. , 1997 .

[12]  N. Sonenberg,et al.  Induction of CD4 expression and human immunodeficiency virus type 1 replication by mutants of the interferon-inducible protein kinase PKR , 1997, Journal of virology.

[13]  S. Rowland-Jones.  HIV infection: where have all the T cells gone? , 1999, The Lancet.

[14]  L. Cosmi,et al.  Limited expression of R5-tropic HIV-1 in CCR5-positive type 1-polarized T cells explained by their ability to produce RANTES, MIP-1alpha, and MIP-1beta. , 2000, Blood.

[15]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. McCune,et al.  The dynamics of CD4+ T-cell depletion in HIV disease , 2001, Nature.

[17]  R. Lempicki,et al.  Gene expression and viral prodution in latently infected, resting CD4+ T cells in viremic versus aviremic HIV-infected individuals , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[18]  T. Speed,et al.  Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.

[19]  A. Gurney,et al.  Interleukin-23 Promotes a Distinct CD4 T Cell Activation State Characterized by the Production of Interleukin-17* , 2003, The Journal of Biological Chemistry.

[20]  K. Becker,et al.  Antigen-Specific Gene Expression Profiles of Peripheral Blood Mononuclear Cells Do Not Reflect Those of T-Lymphocyte Subsets , 2004, Clinical Diagnostic Laboratory Immunology.

[21]  Adeline R. Whitney,et al.  The host response to smallpox: analysis of the gene expression program in peripheral blood cells in a nonhuman primate model. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[22]  L. Espert,et al.  Interferon-induced exonuclease ISG20 exhibits an antiviral activity against human immunodeficiency virus type 1. , 2005, The Journal of general virology.

[23]  Ash A. Alizadeh,et al.  Cell-type specific gene expression profiles of leukocytes in human peripheral blood , 2006, BMC Genomics.

[24]  R. D. Hatton,et al.  Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages , 2005, Nature Immunology.

[25]  Pam Sonnenberg,et al.  How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners. , 2005, The Journal of infectious diseases.

[26]  Qingsheng Li,et al.  Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells , 2005, Nature.

[27]  Stefan H E Kaufmann,et al.  Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis , 2005, Nature Medicine.

[28]  L. Picker.  Immunopathogenesis of acute AIDS virus infection. , 2006, Current opinion in immunology.

[29]  J. Church.  Massive Infection and Loss of Memory CD4+ T Cells in Multiple Tissues During Acute SIV Infection , 2006, Pediatrics.

[30]  P. Sebastiani,et al.  Gene-expression profiling of HIV-1 infection and perinatal transmission in Botswana , 2006, Genes and Immunity.

[31]  P. Pitha,et al.  Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15 , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Y. Ikeda,et al.  Rhesus monkey TRIM5α restricts HIV-1 production through rapid degradation of viral Gag polyproteins , 2007, Nature Medicine.

[33]  D. Weissman,et al.  HIV Envelope Suppresses CD4+ T Cell Activation Independent of T Regulatory Cells1 , 2008, The Journal of Immunology.

[34]  Mahavir Singh,et al.  Early depletion of Mycobacterium tuberculosis-specific T helper 1 cell responses after HIV-1 infection. , 2008, The Journal of infectious diseases.

[35]  Bryan R. G. Williams,et al.  Interferon-inducible antiviral effectors , 2008, Nature Reviews Immunology.

[36]  D. Douek,et al.  Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. , 2008, Blood.

[37]  Jay K Kolls,et al.  Simian immunodeficiency virus–induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut , 2008, Nature Medicine.

[38]  Geneviève Boucher,et al.  HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation , 2009, Nature Medicine.

[39]  J. Routy,et al.  Peripheral Blood CCR4+CCR6+ and CXCR3+CCR6+ CD4+ T Cells Are Highly Permissive to HIV-1 Infection , 2009, The Journal of Immunology.

[40]  R. Wilkinson,et al.  HIV-1 infection impairs the bronchoalveolar T-cell response to mycobacteria. , 2009, American journal of respiratory and critical care medicine.

[41]  Mario Roederer,et al.  Autocrine Production of β-Chemokines Protects CMV-Specific CD4+ T Cells from HIV Infection , 2009, PLoS pathogens.

[42]  L. Rong,et al.  The IFITM Proteins Inhibit HIV-1 Infection , 2010, Journal of Virology.

[43]  R. Koup,et al.  Preferential infection and depletion of Mycobacterium tuberculosis–specific CD4 T cells after HIV-1 infection , 2010, The Journal of experimental medicine.

[44]  Kristen K. Dang,et al.  Genome-Wide mRNA Expression Correlates of Viral Control in CD4+ T-Cells from HIV-1-Infected Individuals , 2010, PLoS pathogens.

[45]  J. Brenchley,et al.  Th17 cell dynamics in HIV infection , 2010, Current opinion in HIV and AIDS.

[46]  G. Superti-Furga,et al.  IFIT1 is an antiviral protein that recognizes 5′-triphosphate RNA , 2011, Nature Immunology.

[47]  J. Grivel,et al.  Selective transmission of R5 HIV-1 variants: where is the gatekeeper? , 2011, Journal of Translational Medicine.

[48]  Matthew S. Lewis,et al.  Profound early control of highly pathogenic SIV by an effector-memory T cell vaccine , 2011, Nature.